GS-441524 is the main plasma metabolite of the antiviral prodrug RDV, and has a half-life of around 24 hours in human patients. RDV and GS-441524 were both found to be effective in vitro against feline coronavirus strains responsible for feline infectious peritonitis (FIP), a lethal systemic disease affecting domestic cats.
| Attributes | Details | 
|---|---|
| Product Name | GS-441524 Tablets | 
| Storage | Store At 2°C To 20°C | 
| Grade | Pharmaceutcial Grade | 
| Active Ingredient | GS-441524 | 
| CAS | 1191237-69-0 | 
| Form | Tablets | 
| Specification | 20mg/tablets, 40mg/tablets, Or Customized | 
| Packaging | 10 Tablets Per Bag | 
| 12 months | 12 Months | 
| Route of Administration | Intramuscular Or Subcutaneous |